Abstract
Background Uveitis in children and young people is a rare but potentially debilitating condition. Steroid eye drops are the first step in treatment and poor compliance may result in vision-threatening complications. This study aimed to measure compliance with prescribed eye drops prospectively and investigate reasons for non-compliance in a child-specific manner.
Methods 50 patients aged 0-18 years attending a tertiary paediatric uveitis clinic using steroid drops were recruited. Both the child or young person, and parent completed questionnaires about compliance. A subgroup had bottles of Prednisolone 1% drops weighed and dispensed at the first appointment and reweighed at follow-up. The reduction in weight was compared with expected weight change over the interval.
Results The study was completed by 31 patients. Drop errors for all eye drops were reported more than “once a week” by 13 (33.3%) children and young people, and 3 (9.7%) parents. A large proportion of parents could not recall the frequency of drops prescribed to their child (13, 40.6%). Insufficient bottle weight reduction was found in 9 (75%), although this was not associated with self-reported drop errors. Within the eye drop weighing subgroup three (25%) used <50% the expected weight of drops.
Conclusions Eye drop compliance was demonstrated to be poor by all the study outcomes in children and young people with uveitis. Self-reported compliance is unreliable in this population, as subjective responses were not supported by objective bottle weight change. Worryingly, some patients miss more than 50% of drops and may suffer worse disease control.
Clinical implications
What is already known on this topic
Poor drop compliance among children and young people with uveitis has been suggested by a previous retrospective study looking at self-reported compliance.
What this study adds
All subjective and objective metrics in this prospective study suggest steroid eye drop compliance is often poor among children with uveitis.
Parental administration of steroid eye drops and shorter disease duration appear to be associated with improved compliance.
How this study might affect research, practice or policy
Self-reported compliance is highly unreliable and should be treated as such by practising clinicians and any future studies.
Among the patients with drop errors a small but clinically significant number have very poor compliance and miss drops daily. These patients are at high risk for sub-optimal disease control or persistent disease activity and this requires further investigation.
Synopsis/Precis This prospective study of drop compliance in children and young people with non-infectious uveitis suggests drop compliance is poor. Some individuals use drops less than half of the prescribed frequency. Self-reported compliance was highly unreliable.
Competing Interest Statement
Author Laura Steeples works for Roche Products UK Limited and has no conflict of interests in the findings of this study. All other authors confirm they have no competing interests.
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT04148365
Funding Statement
We are grateful for funding from the British and Irish Paediatric Ophthalmology and Strabismus Association (BIPOSA). No author received payment or services from a third party for any aspect of the submitted work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for this study was obtained from Health Research Authority, North East-Newcastle and North Tyneside 2 Research Ethics Committee according to the Declaration of Helsinki (REC reference 19/NE/0367). Participants gave informed consent to participate in the study before taking part. The study protocol was published on ClinicalTrials.gov (Identifier NCT04148365).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Orlaith.McGrath{at}mft.nhs.uk
Laura.Steeples{at}roche.com
Jane.Ashworth{at}mft.nhs.uk
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- PPR
- Person with parental responsibility
- JIA
- Juvenile idiopathic arthritis
- TINU
- Tubulointerstitial nephritis and uveitis
- CYP
- Child or young person